XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,331,000 | -34.2% | 572,963 | -27.1% | 0.00% | -100.0% |
| Q1 2021 | $3,543,000 | +0.2% | 785,701 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $3,537,000 | -2.2% | 719,004 | +17.8% | 0.00% | 0.0% |
| Q3 2020 | $3,618,000 | +180.5% | 610,204 | +25.8% | 0.00% | – |
| Q2 2020 | $1,290,000 | +35.4% | 485,086 | -0.8% | 0.00% | – |
| Q1 2020 | $953,000 | -80.9% | 488,936 | -31.0% | 0.00% | -100.0% |
| Q4 2019 | $4,996,000 | +50.2% | 708,924 | +109.4% | 0.00% | 0.0% |
| Q3 2019 | $3,327,000 | -10.1% | 338,510 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $3,702,000 | +36.7% | 323,676 | +19.9% | 0.00% | 0.0% |
| Q1 2019 | $2,709,000 | -3.6% | 269,882 | +63.2% | 0.00% | – |
| Q4 2018 | $2,810,000 | +137.9% | 165,384 | +146.0% | 0.00% | – |
| Q3 2018 | $1,181,000 | – | 67,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|